# US 8,785,130 B2 · Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 8,785,130 B2 - Document ID: US8785130B2 - Status: Granted - Kind: B2 - Application number: 11/481,046 - Filed: 2006-07-06 - Published: 2007-03-29 - Granted: 2014-07-22 - Earliest claimed: 2005-07-07 - Assignees: Bio-ID Diagnostic Inc. - Applicants: Thuraiayah Vinayagamoorthy - Inventors: Thuraiayah Vinayagamoorthy - Web page: https://patentgrep.com/patent/US8785130B2 ## CPC - C12Q 1/6869: Methods for sequencing - C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction - C12Q 1/686: Polymerase chain reaction [PCR] - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract Disclosed is the use of artificially-generated nucleic acid coded markers to monitor nucleic acid amplification and sequencing reactions designed to detect or analyze biological samples. The markers generally include, along with a unique sequence preferably including coded section designed to represent one or more factors of interest, primer annealing sequences so that the marker may be amplified and sequenced in the same process and using the same amplification and sequencing primers as for the sample target. The invention also relates to the marker itself, and other uses, such as identifying the origin of various materials or products. ## Claims ### Claim 1 A method of testing for the presence of a target nucleic acid in a sample, the method comprising: (i) performing amplification, comprising combining the sample, a marker nucleic acid, and a forward and a reverse amplification primer, wherein: the forward and reverse primers are fully complementary to forward and reverse primer annealing sites on the target nucleic acid and on the marker nucleic acid, the target nucleic acid comprises a characteristic sequence, and the marker nucleic acid comprises a known unique sequence, which is different from the characteristic sequence and contains a coding sequence and a homonucleotide sequence upstream of the coding sequence, the homonucleotlde sequence comprising at least as many bases in length as the characteristic sequence, thereby generating a marker amplicon containing the unique sequence, and, when the target nucleic acid sequence is present in the sample, a target amplicon containing the characteristic sequence; (ii) performing sequencing, thereby identifying the sequence of at least part of the coding sequence and, when the target nucleic acid is present in the sample, at least part of the characteristic sequence, wherein: the sequencing comprises combining the amplicon or amplicons generated in step (i) and a sequencing primer that is complementary to a sequencing primer annealing site in the marker ampiicon and to a sequencing primer annealing site in the target amplicon, and the sequencing further comprises a detection step using an automated sequencing machine, wherein a channel for detecting a nucleotide in the homonucleotide sequence is turned off for at least a portion of the detection step; thereby determining the presence or absence of the target nucleic acid sequence in the sample. ### Claim 2 (depends on 1) The method of claim 1, wherein the coding sequence encodes specific information according to a pre-determined artificial code, and wherein the method further comprises decoding said coding sequence by reference to said artificial predetermined code, thereby extracting the specific information. ### Claim 3 (depends on 2) The method of claim 2, wherein said coding sequence includes a plurality of clusters of bases incorporating said artificial code, separated by one or more sequences of homonucleotides acting as coding spacers. ### Claim 4 (depends on 2) The method of claim 2, wherein said sample and said marker are contained in a solution obtained from an unknown target source, and information revealed from said coding sequence is used to identify said unknown source of said solution. ### Claim 5 (depends on 1) The method of claim 1, wherein the amplification in step (i) is carried out by polymerase chain reaction. ### Claim 6 (depends on 1) The method of claim 1, wherein the sample is a first sample and the marker nucleic acid is a first marker nucleic acid and the method is used to test multiple samples and further comprises carrying out steps (i) and (ii) on one or more additional samples using the forward and reverse amplification primers, the sequencing primer, and for each additional sample, an additional marker nucleic acid, wherein each additional marker nucleic acid contains the forward and reverse amplification primer binding sites and a unique nucleotide sequence that is different from the characteristic sequence and different from the unique sequence of the first marker nucleic acid wherein detection of two or more unique marker nucleotide sequences in any sample thereby reveals cross-contamination. ### Claim 7 (depends on 1) The method of claim 1, wherein said sample is obtained from a source that may include an inhibitor of said amplification and the method further comprises determining that the amplification was not inhibited by said inhibitor, based on the sequencing of the at least part of the coding sequence. ### Claim 8 (depends on 1) The method of claim 1, wherein the characteristic sequence is a first characteristic sequence, the marker nucleic acid is a first marker nucleic acid, the forward and reverse primers are first forward and reverse amplification primers, said target nucleic acid further comprises one or more additional characteristic sequences distinct from the first characteristic sequence, and step (i) further comprises combining, in the same reaction, for each of the additional characteristic sequences: a set of additional forward and reverse amplification primers, which primers are distinct from the first forward and reverse primers and are complementary to sites flanking the additional characteristic sequence, and an additional marker, which additional marker comprises sites complementary to the additional amplification primers and an additional unique sequence that is distinct from the unique sequence in the first marker, and step (ii) further comprises sequencing at least part of each additional characteristic sequence and at least part of the unique sequence in each additional marker. ### Claim 9 (depends on 1) The method of claim 1, wherein the sequencing in step (ii) further comprises providing a polymerase, nucleotides, and chain-terminating nucleotides under conditions that permit hybridization of the sequencing primer to sequencing primer annealing sites in the marker amplicon and, when present, in the target amplicon, and extension of the sequencing primer. ### Claim 10 (depends on 1) The method of claim 1, wherein the sequencing primer annealing site in the marker amplicon and, where present, in the target amplicon, is located between the respective forward and reverse primer binding sites.